Baseline VEGFR2 levels are associated with progression-free survival (but not overall survival) in cediranib studies in hepatocellular carcinoma,33 although were not prognostic (for progression-free survival or overall survival) in colorectal cancer.34 The gene discussed is KDR; the disease is hepatocellular carcinoma.